ASCOT: The Australasian COVID-19 Trial

Australasian COVID-19 Trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

Trial Overview

0 patients enrolled in trial

0 patients randomised

23 sites activated

News

Macquarie Group Foundation commits $1 million to the AustralaSian COVID-19 Trial
July 2, 2020
The AustralaSian COVID-19 Trial (ASCOT) has received a significant funding commitment of $1 million from the Macquarie Group Foundation.
- Read more
A Consumer Representative's experience working on a COVID-19 clinical trial
June 24, 2020
Sue Anderson is the Consumer Representative on the AustralaSian COVID-19 Clinical Trial (ASCOT) Steering Committee. She writes here of her experience.
- Read more
Getting a clinical trial site up and running
June 17, 2020
Setting up a clinical trial can take many months, even years. However, over the last six months, research teams around the globe have been pushed to their limits to set up and conduct randomised clinical trials to the same gold standard that is expected during non-COVID-19 times, but in record time.
- Read more